Literature DB >> 33884753

Reduced synchrony in alpha oscillations during life predicts post mortem neurofibrillary tangle density in early-onset and atypical Alzheimer's disease.

Kamalini G Ranasinghe1, Cathrine Petersen1, Kiwamu Kudo2,3, Danielle Mizuiri2, Katherine P Rankin1, Gil D Rabinovici1,2, Maria Luisa Gorno-Tempini1, William W Seeley1,4, Salvatore Spina1, Bruce L Miller1, Keith Vossel1,5, Lea T Grinberg1,4,6, Srikantan S Nagarajan2.   

Abstract

INTRODUCTION: Neurophysiological manifestations selectively associated with amyloid beta and tau depositions in Alzheimer's disease (AD) are useful network biomarkers to identify peptide specific pathological processes. The objective of this study was to validate the associations between reduced neuronal synchrony within alpha oscillations and neurofibrillary tangle (NFT) density in autopsy examination, in patients with AD.
METHODS: In a well-characterized clinicopathological cohort of AD patients (n = 13), we quantified neuronal synchrony within alpha (8-12 Hz) and delta-theta (2-8 Hz) oscillations, using magnetoencephalography during the disease course, within six selected neocortical and hippocampal regions, including angular gyrus, superior temporal gurus, middle frontal gyrus, primary motor cortex, CA1, and subiculum, and correlated these with regional NFT density quantified at histopathological examination.
RESULTS: Abnormal synchrony in alpha, but not in delta-theta, significantly predicted the NFT density at post mortem neuropathological examination. DISCUSSION: Reduced alpha synchrony is a sensitive neurophysiological index associated with pathological tau, and a potential network biomarker for clinical trials, to gauge the extent of network dysfunction and the degree of rescue in treatments targeting tau pathways in AD.
© 2021 the Alzheimer's Association.

Entities:  

Keywords:  Alzheimer's disease; alpha oscillations; magnetoencephalography; neurofibrillary tangle density; neuropathology; neurophysiology

Mesh:

Year:  2021        PMID: 33884753      PMCID: PMC8528895          DOI: 10.1002/alz.12349

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  57 in total

1.  Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease.

Authors:  P Giannakopoulos; F R Herrmann; T Bussière; C Bouras; E Kövari; D P Perl; J H Morrison; G Gold; P R Hof
Journal:  Neurology       Date:  2003-05-13       Impact factor: 9.910

Review 2.  Network abnormalities and interneuron dysfunction in Alzheimer disease.

Authors:  Jorge J Palop; Lennart Mucke
Journal:  Nat Rev Neurosci       Date:  2016-11-10       Impact factor: 34.870

3.  Sleep as a Potential Biomarker of Tau and β-Amyloid Burden in the Human Brain.

Authors:  Joseph R Winer; Bryce A Mander; Randolph F Helfrich; Anne Maass; Theresa M Harrison; Suzanne L Baker; Robert T Knight; William J Jagust; Matthew P Walker
Journal:  J Neurosci       Date:  2019-06-17       Impact factor: 6.167

4.  Profound degeneration of wake-promoting neurons in Alzheimer's disease.

Authors:  Jun Oh; Rana A Eser; Alexander J Ehrenberg; Dulce Morales; Cathrine Petersen; Jessica Kudlacek; Sara R Dunlop; Panos Theofilas; Elisa D P F Resende; Celica Cosme; Eduardo J L Alho; Salvatore Spina; Christine M Walsh; Bruce L Miller; William W Seeley; Jackson C Bittencourt; Thomas C Neylan; Helmut Heinsen; Lea T Grinberg
Journal:  Alzheimers Dement       Date:  2019-08-12       Impact factor: 21.566

5.  Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.

Authors:  Rik Ossenkoppele; Daniel R Schonhaut; Michael Schöll; Samuel N Lockhart; Nagehan Ayakta; Suzanne L Baker; James P O'Neil; Mustafa Janabi; Andreas Lazaris; Averill Cantwell; Jacob Vogel; Miguel Santos; Zachary A Miller; Brianne M Bettcher; Keith A Vossel; Joel H Kramer; Maria L Gorno-Tempini; Bruce L Miller; William J Jagust; Gil D Rabinovici
Journal:  Brain       Date:  2016-03-08       Impact factor: 13.501

6.  Alzheimer's disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation.

Authors:  Cathrine Petersen; Amber L Nolan; Elisa de Paula França Resende; Zachary Miller; Alexander J Ehrenberg; Maria Luisa Gorno-Tempini; Howard J Rosen; Joel H Kramer; Salvatore Spina; Gil D Rabinovici; Bruce L Miller; William W Seeley; Helmut Heinsen; Lea Tenenholz Grinberg
Journal:  Acta Neuropathol       Date:  2019-06-27       Impact factor: 17.088

7.  Abnormalities of cortical neural synchronization mechanisms in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study.

Authors:  Claudio Babiloni; Claudio Del Percio; Roberta Lizio; Giuseppe Noce; Susanna Cordone; Susanna Lopez; Andrea Soricelli; Raffaele Ferri; Maria Teresa Pascarelli; Flavio Nobili; Dario Arnaldi; Dag Aarsland; Francesco Orzi; Carla Buttinelli; Franco Giubilei; Marco Onofrj; Fabrizio Stocchi; Paola Stirpe; Peter Fuhr; Ute Gschwandtner; Gerhard Ransmayr; Georg Caravias; Heinrich Garn; Fabiola Sorpresi; Michela Pievani; Giovanni B Frisoni; Fabrizia D'Antonio; Carlo De Lena; Bahar Güntekin; Lutfu Hanoğlu; Erol Başar; Görsev Yener; Derya Durusu Emek-Savaş; Antonio Ivano Triggiani; Raffaella Franciotti; Maria Francesca De Pandis; Laura Bonanni
Journal:  Neurobiol Aging       Date:  2017-04-05       Impact factor: 4.673

8.  Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET.

Authors:  Renaud La Joie; Adrienne V Visani; Suzanne L Baker; Jesse A Brown; Viktoriya Bourakova; Jungho Cha; Kiran Chaudhary; Lauren Edwards; Leonardo Iaccarino; Mustafa Janabi; Orit H Lesman-Segev; Zachary A Miller; David C Perry; James P O'Neil; Julie Pham; Julio C Rojas; Howard J Rosen; William W Seeley; Richard M Tsai; Bruce L Miller; William J Jagust; Gil D Rabinovici
Journal:  Sci Transl Med       Date:  2020-01-01       Impact factor: 17.956

9.  Network Disruption and Cerebrospinal Fluid Amyloid-Beta and Phospho-Tau Levels in Mild Cognitive Impairment.

Authors:  Leonides Canuet; Sandra Pusil; María Eugenia López; Ricardo Bajo; José Ángel Pineda-Pardo; Pablo Cuesta; Gerardo Gálvez; José María Gaztelu; Daniel Lourido; Guillermo García-Ribas; Fernando Maestú
Journal:  J Neurosci       Date:  2015-07-15       Impact factor: 6.167

10.  Neurophysiological signatures of Alzheimer's disease and frontotemporal lobar degeneration: pathology versus phenotype.

Authors:  Saber Sami; Nitin Williams; Laura E Hughes; Thomas E Cope; Timothy Rittman; Ian T S Coyle-Gilchrist; Richard N Henson; James B Rowe
Journal:  Brain       Date:  2018-08-01       Impact factor: 13.501

View more
  3 in total

1.  Amyloid beta induces Fmr1-dependent translational suppression and hyposynchrony of neural activity via phosphorylation of eIF2α and eEF2.

Authors:  Simon Lizarazo; Yeeun Yook; Nien-Pei Tsai
Journal:  J Cell Physiol       Date:  2022-04-17       Impact factor: 6.513

2.  Altered excitatory and inhibitory neuronal subpopulation parameters are distinctly associated with tau and amyloid in Alzheimer's disease.

Authors:  Kamalini G Ranasinghe; Parul Verma; Chang Cai; Xihe Xie; Kiwamu Kudo; Xiao Gao; Hannah Lerner; Danielle Mizuiri; Amelia Strom; Leonardo Iaccarino; Renaud La Joie; Bruce L Miller; Maria Luisa Gorno-Tempini; Katherine P Rankin; William J Jagust; Keith Vossel; Gil D Rabinovici; Ashish Raj; Srikantan S Nagarajan
Journal:  Elife       Date:  2022-05-26       Impact factor: 8.713

3.  Spatially resolved neural slowing predicts impairment and amyloid burden in Alzheimer's disease.

Authors:  Alex I Wiesman; Daniel L Murman; Rebecca A Losh; Mikki Schantell; Nicholas J Christopher-Hayes; Hallie J Johnson; Madelyn P Willett; Sara L Wolfson; Kathryn L Losh; Craig M Johnson; Pamela E May; Tony W Wilson
Journal:  Brain       Date:  2022-06-30       Impact factor: 15.255

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.